NDC 63323-482 – Xylocaine

Lidocaine Hydrochloride Anhydrous 10 mg/mL; Epinephrine Bitartrate .01 mg/mL · Injection, Solution · Infiltration, Perineural

Human Prescription Drug 5 recalls

Product NDC63323-482

Product details

Brand name
Xylocaine
Generic name
Lidocaine Hydrochloride,epinephrine Bitartrate
Labeler
Fresenius Kabi USA, LLC
Dosage form
Injection, Solution
Route
Infiltration, Perineural
Marketing category
NDA · NDA006488
Marketed since
August 12, 2010
Listing expires
December 31, 2026
Pharmacologic class
Amide Local Anesthetic; Antiarrhythmic; Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist

Active ingredients

Uses, dosage, side effects and warnings for Xylocaine →

Package NDC codes (4)

Package NDCDescriptionSince
63323-482-1725 VIAL, MULTI-DOSE in 1 TRAY (63323-482-17) / 10 mL in 1 VIAL, MULTI-DOSE (63323-482-01)Aug 12, 2010
63323-482-2625 VIAL, MULTI-DOSE in 1 TRAY (63323-482-26) / 20 mL in 1 VIAL, MULTI-DOSE (63323-482-41)Aug 12, 2010
63323-482-2725 VIAL, MULTI-DOSE in 1 TRAY (63323-482-27) / 20 mL in 1 VIAL, MULTI-DOSE (63323-482-03)Aug 12, 2010
63323-482-5725 VIAL, MULTI-DOSE in 1 TRAY (63323-482-57) / 50 mL in 1 VIAL, MULTI-DOSE (63323-482-05)Aug 12, 2010

Recalls mentioning this NDC

Other Xylocaine products